Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1

Bee K. Tan(Cambridge University Hospitals NHS Foundation Trust), Harpal Randeva(Centre for Advanced Study)
Cardiovascular Research
May 4, 2009
Cited by 115


Related Papers